These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 27141643

  • 1. [Antimicrobial Properties of Eremoxylarin A Produced by Ascomycete of Sordariomycetes in Submerged Culture].
    Efremenkova OV, Vasiljeva BF, Zenkova VA, Korolev AM, Lusikov YN, Efimenko TA, Malanicheva IA, Mirchink EP, Isakova EB, Bilanenko EN, Kamzolkina OV.
    Antibiot Khimioter; 2015; 60(11-12):23-8. PubMed ID: 27141643
    [Abstract] [Full Text] [Related]

  • 2. Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2013.
    Coombs GW, Nimmo GR, Daly DA, Le TT, Pearson JC, Tan HL, Robinson JO, Collignon PJ, McLaws ML, Turnidge JD, Australian Group on Antimicrobial Resistance.
    Commun Dis Intell Q Rep; 2014 Dec 31; 38(4):E309-19. PubMed ID: 25631593
    [Abstract] [Full Text] [Related]

  • 3. RIP-V improves murine survival in a sepsis model by down-regulating RNAIII expression and α-hemolysin release of methicillin-resistant Staphylococcus aureus.
    Ma B, Zhou Y, Li M, Yu Q, Xue X, Li Z, Da F, Hou Z, Luo X.
    Pharmazie; 2015 Feb 31; 70(2):81-7. PubMed ID: 25997246
    [Abstract] [Full Text] [Related]

  • 4. Artesunate in combination with oxacillin protect sepsis model mice challenged with lethal live methicillin-resistant Staphylococcus aureus (MRSA) via its inhibition on proinflammatory cytokines release and enhancement on antibacterial activity of oxacillin.
    Jiang W, Li B, Zheng X, Liu X, Cen Y, Li J, Pan X, Cao H, Zheng J, Zhou H.
    Int Immunopharmacol; 2011 Aug 31; 11(8):1065-73. PubMed ID: 21396483
    [Abstract] [Full Text] [Related]

  • 5. In vivo antibacterial activity and pharmacological properties of the membrane-active glycopeptide antibiotic YV11455.
    Yarlagadda V, Konai MM, Manjunath GB, Prakash RG, Mani B, Paramanandham K, Ranjan SB, Ravikumar R, Chakraborty SP, Roy S, Haldar J.
    Int J Antimicrob Agents; 2015 Jun 31; 45(6):627-34. PubMed ID: 25900818
    [Abstract] [Full Text] [Related]

  • 6. Restoring methicillin-resistant Staphylococcus aureus susceptibility to β-lactam antibiotics.
    Tan CM, Therien AG, Lu J, Lee SH, Caron A, Gill CJ, Lebeau-Jacob C, Benton-Perdomo L, Monteiro JM, Pereira PM, Elsen NL, Wu J, Deschamps K, Petcu M, Wong S, Daigneault E, Kramer S, Liang L, Maxwell E, Claveau D, Vaillancourt J, Skorey K, Tam J, Wang H, Meredith TC, Sillaots S, Wang-Jarantow L, Ramtohul Y, Langlois E, Landry F, Reid JC, Parthasarathy G, Sharma S, Baryshnikova A, Lumb KJ, Pinho MG, Soisson SM, Roemer T.
    Sci Transl Med; 2012 Mar 21; 4(126):126ra35. PubMed ID: 22440737
    [Abstract] [Full Text] [Related]

  • 7. Frequency and treatment of methicillin resistant Staphylococcus aureus in obstetric and gynaecological sepsis.
    Butt IJ, Khan S, Butt S, Bhutta S.
    J Coll Physicians Surg Pak; 2013 Oct 21; 23(10):708-10. PubMed ID: 24112255
    [Abstract] [Full Text] [Related]

  • 8. Marine bacteria: potential sources for compounds to overcome antibiotic resistance.
    Eom SH, Kim YM, Kim SK.
    Appl Microbiol Biotechnol; 2013 Jun 21; 97(11):4763-73. PubMed ID: 23640363
    [Abstract] [Full Text] [Related]

  • 9. Antistaphylococcal activity of WCK 771, a tricyclic fluoroquinolone, in animal infection models.
    Patel MV, De Souza NJ, Gupte SV, Jafri MA, Bhagwat SS, Chugh Y, Khorakiwala HF, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 2004 Dec 21; 48(12):4754-61. PubMed ID: 15561853
    [Abstract] [Full Text] [Related]

  • 10. [Antimicrobial activity of Laetiporus sulphureus strains grown in submerged culture].
    Ershova EIu, Tikhonova OV, Lur'e LM, Efremenkova OV, Kamzolkina OV, Dudnik IuV.
    Antibiot Khimioter; 2003 Dec 21; 48(1):18-22. PubMed ID: 12741318
    [Abstract] [Full Text] [Related]

  • 11. Effect of granulocyte colony-stimulating factor in experimental methicillin resistant Staphylococcus aureus sepsis.
    Alp E, Gozukucuk S, Canoz O, Kirmaci B, Doganay M.
    BMC Infect Dis; 2004 Oct 18; 4():43. PubMed ID: 15491501
    [Abstract] [Full Text] [Related]

  • 12. In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections.
    Desbois AP, Gemmell CG, Coote PJ.
    Int J Antimicrob Agents; 2010 Jun 18; 35(6):559-65. PubMed ID: 20206480
    [Abstract] [Full Text] [Related]

  • 13. Treatment of methicillin-resistant Staphylococcus aureus in neonatal mice: lysostaphin versus vancomycin.
    Placencia FX, Kong L, Weisman LE.
    Pediatr Res; 2009 Apr 18; 65(4):420-4. PubMed ID: 19127212
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Melittin, a honeybee venom‑derived antimicrobial peptide, may target methicillin‑resistant Staphylococcus aureus.
    Choi JH, Jang AY, Lin S, Lim S, Kim D, Park K, Han SM, Yeo JH, Seo HS.
    Mol Med Rep; 2015 Nov 18; 12(5):6483-90. PubMed ID: 26330195
    [Abstract] [Full Text] [Related]

  • 17. Antibacterial effect of octylcyanoacrylate against methicillin-resistant Staphylococcus aureus isolates from patients with chronic suppurative otitis media.
    Jang CH, Park H, Choi CH, Cho YB, Park IY.
    In Vivo; 2008 Nov 18; 22(6):763-5. PubMed ID: 19181004
    [Abstract] [Full Text] [Related]

  • 18. Discovery of Linear Low-Cationic Peptides to Target Methicillin-Resistant Staphylococcus aureus in Vivo.
    Liu Y, Song M, Ding S, Zhu K.
    ACS Infect Dis; 2019 Jan 11; 5(1):123-130. PubMed ID: 30372023
    [Abstract] [Full Text] [Related]

  • 19. [Persistent bacteremia due to methicillin-resistant Staphylococcus aureus. A result of inadequate treatment].
    Parra-Ruiz J, Tomas-Jiménez C, Muñoz-Medina L, Hernández-Quero J.
    Enferm Infecc Microbiol Clin; 2009 Jun 11; 27(6):372-3. PubMed ID: 19339080
    [No Abstract] [Full Text] [Related]

  • 20. In vitro and in vivo toxicity and antibacterial efficacy of melittin against clinical extensively drug-resistant bacteria.
    Askari P, Namaei MH, Ghazvini K, Hosseini M.
    BMC Pharmacol Toxicol; 2021 Jul 14; 22(1):42. PubMed ID: 34261542
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.